113 related articles for article (PubMed ID: 23067925)
1. Global systolic load, left ventricular hypertrophy, and atrial fibrillation.
Bang CN; Greve AM; Wachtell K; Kober L
Am Heart J; 2012 Oct; 164(4):e13. PubMed ID: 23067925
[No Abstract] [Full Text] [Related]
2. A therapeutic opportunity that needs to be optimized.
Jolobe OM
Am Heart J; 2012 Oct; 164(4):e11. PubMed ID: 23067924
[No Abstract] [Full Text] [Related]
3. Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.
Jolobe OM
Eur J Intern Med; 2010 Feb; 21(1):55. PubMed ID: 20122621
[No Abstract] [Full Text] [Related]
4. Evolving strategies for the use of spironolactone in cardiovascular disease.
Jolobe OM
Eur J Intern Med; 2013 Jun; 24(4):303-9. PubMed ID: 23245930
[TBL] [Abstract][Full Text] [Related]
5. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy regression and atrial fibrillation incidence.
Hyman MH
JAMA; 2007 Jan; 297(1):40; author reply 40-1. PubMed ID: 17200471
[No Abstract] [Full Text] [Related]
7. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis.
Dahl JS; Christensen NL; Videbæk L; Poulsen MK; Carter-Storch R; Hey TM; Pellikka PA; Steffensen FH; Møller JE
Circ Cardiovasc Imaging; 2014 Jan; 7(1):142-8. PubMed ID: 24173271
[TBL] [Abstract][Full Text] [Related]
8. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
9. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
Rieck ÅE; Cramariuc D; Boman K; Gohlke-Bärwolf C; Staal EM; Lønnebakken MT; Rossebø AB; Gerdts E
Hypertension; 2012 Jul; 60(1):90-7. PubMed ID: 22647889
[TBL] [Abstract][Full Text] [Related]
10. Systolic hypertension is also the neglected stepsister of aortic stenosis.
Jolobe OM
Am J Med; 2008 Sep; 121(9):e21, author reply e23. PubMed ID: 18724948
[No Abstract] [Full Text] [Related]
11. Clinicians treating hypertension need to mind their "P's" (precision) and "Q's"(quantitation): a lesson from left ventricular hypertrophy regression and atrial fibrillation.
Giles TD
J Clin Hypertens (Greenwich); 2007 May; 9(5):314-5. PubMed ID: 17485965
[No Abstract] [Full Text] [Related]
12. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
Stewart RA; Kerr AJ; Cowan BR; Young AA; Occleshaw C; Richards AM; Edwards C; Whalley GA; Freidlander D; Williams M; Doughty RN; Zeng I; White HD;
Am Heart J; 2008 Aug; 156(2):348-55. PubMed ID: 18657667
[TBL] [Abstract][Full Text] [Related]
13. [Hypertensive patient with enlarged heart. Caution, risk of atrial fibrillation!].
MMW Fortschr Med; 2006 May; 148(21):62. PubMed ID: 16796195
[No Abstract] [Full Text] [Related]
14. Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension.
Hennersdorf MG; Schueller PO; Steiner S; Strauer BE
Hypertens Res; 2007 Jun; 30(6):535-40. PubMed ID: 17664857
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study.
Vagaonescu TD; Wilson AC; Kostis JB
Hypertension; 2008 Jun; 51(6):1552-6. PubMed ID: 18391094
[TBL] [Abstract][Full Text] [Related]
16. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and blood pressure.
Harv Heart Lett; 2009 Jun; 19(10):6. PubMed ID: 19681208
[No Abstract] [Full Text] [Related]
18. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Nienaber CA; Ray S; Egstrup K; Pedersen TR; Køber L; Willenheimer R; Wachtell K
Int J Cardiol; 2013 Jun; 166(1):72-6. PubMed ID: 21996417
[TBL] [Abstract][Full Text] [Related]
19. Of hammers and screws: renin-angiotensin-aldosterone system inhibition to prevent atrial fibrillation in patients with hypertension.
Kirchhof P; Fabritz L
Eur Heart J; 2014 May; 35(18):1169-71. PubMed ID: 24566798
[No Abstract] [Full Text] [Related]
20. Antihypertensive Treatments in Patients Affected by Aortic Valve Stenosis.
Poggio P; Folesani G; Raffa GM; Songia P; Valenti V; Myasoedova V; Parolari A
Curr Pharm Des; 2017; 23(8):1188-1194. PubMed ID: 27881062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
